Skip to main content
. 2021 May 11;12(10):967–981. doi: 10.18632/oncotarget.27955

Table 1. Clinical characteristics of patients included for the sequencing analyses.

Patient Age Gender Pathology Molecular stratification Location Date of diagnosis Date of death
Pt 8 57 M GBM IDH wt, ATRX pos, MGMT not assessed Right frontal 3/24/2017 4/3/2018
Pt 9 70 M GBM IDH wt, ATRX pos, MGMT un-methylated Left frontal 3/30/2017 1/4/2018
Pt 10 59 M GBM IDH wt, ATRX pos, MGMT methylated (intermediate) Left frontal 3/31/2017 alive
Pt 12 61 F GBM IDH wt, ATRX pos, MGMT not assessed Right Parietal 7/7/2017 alive
Pt 13 70 F GBM IDH wt, ATRX pos, MGMT not assessed Left frontal 7/10/2017 12/24/2017